The Discounted Cash Flow (DCF) valuation of Castle Biosciences Inc (CSTL) is (179.06) USD. With the latest stock price at 28.87 USD, the upside of Castle Biosciences Inc based on DCF is -720.2%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 8.2% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (458.84) - (112.73) | (179.06) |
| Upside | -1689.3% - -490.5% | -720.2% |